We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CAT Strategic Metals Corporation | CSE:CAT | CSE | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.005 | 0.005 | 0.01 | 0.005 | 0.005 | 0.005 | 49,000 | 01:00:00 |
RNS Number:8618H J.P. Morgan Securities Ld(EMM) 24 February 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM ...... J.P. Morgan Securities Ltd ................................. .................................... Date of disclosure ...24th February 2003............... ........................ ................................. Contact name ............Sara Moth.................. ........................... ............................. Telephone number ............020 7325 5808... ................................. .......................... Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: Cambridge Antibody Technology Group plc AMENDMENT If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element (s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price. For full details of disclosure requirements see Rules 8 and 38 of the code. If in doubt contact the Monitoring Section of the Panel, Tel. No: 020 7638 0129 CONNECTED EXEMPT MARKET-MAKERS; DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in .....................Cambridge Antibody Technology Group plc... .......(name of company) Class of security .......................................Ordinary Shares...... .................................. Date of disclosure .................................24th February 2003......... ................................. Date of dealing .......................................21st February 2003...... ................................. Name of EMM ....................................J.P. Morgan Securities Ltd...... ........................... Name of offeree/offeror with whom connected .........Cambridge Antibody Technology Group plc ......... Total number of securities purchased 34,682 Highest price paid* 4.30 GBP Lowest price paid* 4.30 GBP Total number of securities sold 34,682 Highest price received* 4.32 GBP Lowest price received* 4.29 GBP * Currency must be stated This information is provided by RNS The company news service from the London Stock Exchange END EMMSEMFFLSDSEEE
1 Year CAT Strategic Metals Chart |
1 Month CAT Strategic Metals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions